Flagstaff, Arizona
Regenerative therapy, delivered in Flagstaff.
Exosomes and mesenchymal stem cells — administered by a Mend practitioner at your home, hotel, or private facility anywhere in Flagstaff.
Request a ConsultationThe Mend Concierge Model
Regenerative care at your location of choice.
Most regenerative therapy requires you to travel to a clinic, sit in a waiting room, and receive treatment in an environment designed for throughput, not experience.
Mend operates differently. We bring everything to you — the practitioner, the products, the equipment, and the protocol. Your home, your hotel room, your ranch. Anywhere in the greater Flagstaff area.
This isn't just convenience. The ability to rest, recover, and receive care in your own environment is part of the therapeutic experience.
Consultation & protocol design
A thorough intake — your history, goals, biomarkers, and any prior imaging. Your practitioner designs the approach before arrival.
We confirm your location
Home, hotel, private facility — anywhere in Flagstaff. We coordinate timing around you, not a clinic schedule.
On-site administration
Your practitioner arrives with all equipment and products. Cellular biologics are cold-chain verified at arrival and administered by site-specific injection.
Follow-up & protocol tracking
Post-treatment check-in, symptom tracking, and protocol adjustments through your Mend membership or follow-up consult.
Two Modalities
The regenerative toolkit.
Each therapy has a distinct mechanism, regulatory status, and clinical application. Your practitioner will recommend the appropriate approach — or combination — based on your goals and clinical picture.
Exosomes
Enhance cellular communication that supports healing processes.
- Derived from ethically screened donor sources
- Third-party lot testing — CoA available on request
- Cold-chain verified at time of administration
- Often used in combination with MSC protocols
MSCs — Mesenchymal Stem Cells
Support natural stem cell signaling involved in repair and regeneration.
- Ethically donated umbilical cord tissue
- Comprehensive donor health screening per lot
- Certificate of analysis provided upon request
- Viability confirmed before administration
The Mechanism
What MSCs actually do.
Phase 01 · Signaling
They talk to the tissue.
MSCs act primarily as signaling cells. Rather than replacing damaged tissue directly, they release growth factors and cytokines that influence how surrounding cells behave — a paracrine effect.
Phase 02 · Inflammation
They modulate the local environment.
MSCs can shift the local immune response away from a chronic inflammatory state. In a joint, persistent low-grade inflammation is part of what drives ongoing degeneration.
Phase 03 · Recruitment
They call in the body's own repair.
Signaling factors recruit resident cells to the area and support local blood supply — meaning the repair work is largely done by the patient's own tissue.
Phase 04 · Duration
The effect outlasts the cells.
Injected cells do not persist indefinitely. The clinical rationale rests on the signaling cascade they initiate, not on long-term engraftment.
The Messengers
What exosomes are.
Exosomes are extracellular vesicles — small packets of signaling material released by cells. They carry proteins and genetic messaging that influence how recipient cells behave. They are the messengers, not the cells themselves.
Two Tools, Compared
MSCs and exosomes, side by side.
| MSC | Exosome | |
|---|---|---|
| What it is | Living cells | Cell-derived vesicles — not living cells |
| Primary mechanism | Paracrine signaling and local immune modulation | Direct delivery of signaling molecules |
| Cell content | Contains whole cells | Acellular — contains no cells |
| Storage and handling | Viability preservation, cold-chain, passage-controlled | Cold-chain verified, lot-tested |
| Typical use in joint therapy | Site-specific injection, often a single administration | Often paired with MSCs, or used independently for signaling support |
Honest, By Design
What the evidence supports.
Osteoarthritis and joint applications are an active research area with encouraging but still-developing evidence.
Results vary by individual, joint, and severity.
These are not FDA-approved treatments for orthopedic conditions.
Candidacy is determined clinically, case by case.
Areas of Interest
Where patients seek regenerative support.
The following reflect the areas most commonly explored through regenerative protocols. Individual outcomes vary. We do not claim these therapies treat or cure any condition.
Shoulder & Elbow
Rotator cuff, tennis elbow, bicep tendons, and shoulder joint health.
Exosome and MSC protocols explored for tendon support
Knees
Knee joint, cartilage health, meniscus support, and post-surgical recovery protocols.
One of the most researched areas in regenerative protocols
Autoimmune Support
Patients with autoimmune conditions exploring adjunctive regenerative support alongside conventional care.
Discussed in consultation — not a replacement for conventional treatment
Sports & Orthopedic Injuries
Ligament, tendon, and muscle injuries in active individuals exploring supportive regenerative protocols.
Case-by-case evaluation based on injury type and severity
Chronic Pain & Inflammation
Long-standing musculoskeletal pain where conventional interventions have provided limited relief.
Case-by-case evaluation required — not appropriate for all patients
Arthritic Pain
Patients with joint pain secondary to arthritis exploring regenerative support protocols.
Often combined with conventional pain management
Anti-Aging & Longevity
Patients interested in regenerative biologics as part of a broader longevity and optimization protocol.
Exploratory — no anti-aging claims are made or implied
Hair & Skin
Protocols for scalp and skin using cellular signaling approaches.
Exploratory — individual results vary
Product Standards
We only use what we'd use on ourselves.
Choosing a regenerative therapy provider means trusting the products being administered into your body. We apply strict criteria to every cellular biologic we work with — and those standards are non-negotiable.
Before any product is used, we verify donor screening records, review the certificate of analysis for the specific lot, and confirm cold-chain integrity. These are not optional steps — they are baseline requirements.
Comprehensive donor screening
Every lot is sourced from donors with complete health, lifestyle, and family history assessments. Communicable disease testing is confirmed before use.
Certificate of analysis — per lot
Third-party viability and potency reports for each specific lot. Available to you upon request. We do not use products without documented lot-level testing.
Passage control for cellular products
We use providers who do not culture cells beyond the fifth passage — limiting genetic drift and minimizing potential inflammatory activity.
Informed consent before every session
You receive a complete explanation of the therapy's experimental status, known risks, and the absence of FDA approval before any treatment begins.
What you need to know — transparently.
These therapies are experimental. Exosome and UC-derived cellular biologic therapies are not FDA-approved for the conditions described on this page. They are offered as investigational, off-label therapies under informed consent.
No disease claims are made. Mend does not claim that any regenerative therapy treats, cures, prevents, or reverses any disease or medical condition. Outcomes vary significantly between individuals.
Not a replacement for conventional care. Regenerative therapy is best understood as adjunctive or exploratory — not a substitute for evidence-based conventional medical treatment.
Informed consent is required. Every patient receives a complete explanation of risks, experimental status, the absence of FDA approval, and alternative options before any session begins.
Product documentation is available. Certificates of analysis and donor screening documentation for the specific product lot used in your session are available upon request.
FAQ
Common Questions
Advanced regenerative care. At your door.
A consultation is the first step — and the only way to determine if regenerative therapy is right for your specific situation.
This page is for informational purposes only and does not constitute medical advice. Regenerative therapies including exosomes and umbilical cord-derived cellular biologics are experimental and not FDA-approved for any therapeutic use. Individual results vary. A consultation with a qualified practitioner is required before treatment. Mend Medical does not guarantee outcomes.